{"title":"Tumolit和青蒿素产品对实验小鼠和大鼠的毒理学试验","authors":"C. Oroian, A. Stuparu, V. Gavrila, T. Oroian","doi":"10.15835/BUASVMCN-ASB:11427","DOIUrl":null,"url":null,"abstract":"This paper presents the experimental results establishing the lethal dose (LD) of the two products considered to have antitumor effect:Tumolit and Artemisinin. For testing, we used an experimental design including two species of gnawers, Swiss mice and Wistar rats. Two experimental groups were used, consisting of 20 Swiss male mice each, as well as two groups of 10 Wistar rats/lot. In interpreting the results of the research and in the development of the experimental protocol, we took into account the toxicity scale after Hodge and Sterner. Initial doses were usedof both products at 200mg / kg / body for each mouse and rat, respectively, administered orallyin single-doses. Between each oral dose, there was one day of rest in order to evaluate possible effects. As mentioned in theProtocol, the dose was increased to500mg dose / kg / body,then to 1000 mg / kg / body, 2000mg / kg / body and then to 5000 mg / kg / body. At this last dose, administration was disrupted in mice. For rats, doses were further increased in three innings to 5000 mg / kg / body, 15,000 mg / kg / body concerned 20,000 mg / kg / body in single oral dose. The administration was done by gavage in a single dose. There were no toxicity effects reported at any dose level applied, which is why we conclude that the two products are practically non-toxic. Â","PeriodicalId":9587,"journal":{"name":"Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies","volume":"72 1","pages":"207-210"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Toxicological Tests of Tumolit and Artemisinin Products on Laboratory Mice and Rats\",\"authors\":\"C. Oroian, A. Stuparu, V. Gavrila, T. Oroian\",\"doi\":\"10.15835/BUASVMCN-ASB:11427\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This paper presents the experimental results establishing the lethal dose (LD) of the two products considered to have antitumor effect:Tumolit and Artemisinin. For testing, we used an experimental design including two species of gnawers, Swiss mice and Wistar rats. Two experimental groups were used, consisting of 20 Swiss male mice each, as well as two groups of 10 Wistar rats/lot. In interpreting the results of the research and in the development of the experimental protocol, we took into account the toxicity scale after Hodge and Sterner. Initial doses were usedof both products at 200mg / kg / body for each mouse and rat, respectively, administered orallyin single-doses. Between each oral dose, there was one day of rest in order to evaluate possible effects. As mentioned in theProtocol, the dose was increased to500mg dose / kg / body,then to 1000 mg / kg / body, 2000mg / kg / body and then to 5000 mg / kg / body. At this last dose, administration was disrupted in mice. For rats, doses were further increased in three innings to 5000 mg / kg / body, 15,000 mg / kg / body concerned 20,000 mg / kg / body in single oral dose. The administration was done by gavage in a single dose. There were no toxicity effects reported at any dose level applied, which is why we conclude that the two products are practically non-toxic. Â\",\"PeriodicalId\":9587,\"journal\":{\"name\":\"Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies\",\"volume\":\"72 1\",\"pages\":\"207-210\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15835/BUASVMCN-ASB:11427\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15835/BUASVMCN-ASB:11427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本文介绍了两种被认为具有抗肿瘤作用的药物Tumolit和青蒿素的致死剂量(LD)的实验结果。为了进行测试,我们采用了包括两种啮齿动物,瑞士小鼠和Wistar大鼠的实验设计。采用2个实验组,每组瑞士雄性小鼠20只,2组Wistar大鼠10只/批。在解释研究结果和制定实验方案时,我们考虑了霍奇和斯特纳事件后的毒性等级。两种产品的初始剂量分别为每只小鼠和大鼠200mg / kg /体,口服单剂量。在每次口服剂量之间,有一天的休息时间,以评估可能的效果。如议定书所述,剂量增加到500mg剂量/ kg /体,然后增加到1000mg / kg /体,2000mg / kg /体,然后增加到5000mg / kg /体。在最后一次给药时,小鼠的给药中断。对大鼠,三局剂量进一步增加至5000 mg / kg /体,15,000 mg / kg /体,单次口服剂量为20,000 mg / kg /体。Â给药方式为单次灌胃。在任何剂量水平下都没有毒性作用的报告,这就是为什么我们得出结论,这两种产品实际上是无毒的。一个
Toxicological Tests of Tumolit and Artemisinin Products on Laboratory Mice and Rats
This paper presents the experimental results establishing the lethal dose (LD) of the two products considered to have antitumor effect:Tumolit and Artemisinin. For testing, we used an experimental design including two species of gnawers, Swiss mice and Wistar rats. Two experimental groups were used, consisting of 20 Swiss male mice each, as well as two groups of 10 Wistar rats/lot. In interpreting the results of the research and in the development of the experimental protocol, we took into account the toxicity scale after Hodge and Sterner. Initial doses were usedof both products at 200mg / kg / body for each mouse and rat, respectively, administered orallyin single-doses. Between each oral dose, there was one day of rest in order to evaluate possible effects. As mentioned in theProtocol, the dose was increased to500mg dose / kg / body,then to 1000 mg / kg / body, 2000mg / kg / body and then to 5000 mg / kg / body. At this last dose, administration was disrupted in mice. For rats, doses were further increased in three innings to 5000 mg / kg / body, 15,000 mg / kg / body concerned 20,000 mg / kg / body in single oral dose. The administration was done by gavage in a single dose. There were no toxicity effects reported at any dose level applied, which is why we conclude that the two products are practically non-toxic. Â